{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:01:10Z","timestamp":1793314870059,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.atherosclerosis.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T17:12:55Z","timestamp":1508778775000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["HDL functionality in type 1 diabetes"],"prefix":"10.1016","volume":"267","author":[{"given":"Shiva","family":"Ganjali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geesje M.","family":"Dallinga-Thie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Simental-Mend\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Pirro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib1","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","article-title":"Classification and diagnosis of diabetes","volume":"39","author":"Association","year":"2016","journal-title":"Diabetes Care."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.autrev.2014.01.020","article-title":"Diagnosis and classification of autoimmune diabetes mellitus","volume":"13","author":"Canivell","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.autrev.2015.11.008","article-title":"Adaptive immune regulation in autoimmune diabetes","volume":"15","author":"Ferretti","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib5","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.metabol.2016.06.008","article-title":"Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus","volume":"65","author":"Manjunatha","year":"2016","journal-title":"Metabolism Clin. Exp."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cct.2014.12.017","article-title":"Resistance Exercise in Already-Active Diabetic Individuals (READI): study rationale, design and methods for a randomized controlled trial of resistance and aerobic exercise in type 1 diabetes","volume":"41","author":"Yardley","year":"2015","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/dmrr.2362","article-title":"Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport","volume":"29","author":"Machado-Lima","year":"2013","journal-title":"Diabetes\/Metabolism Res. Rev."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib8","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/dc06-1161","article-title":"Type 1 diabetes and coronary artery disease","volume":"29","author":"Orchard","year":"2006","journal-title":"Diabetes Care."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib9","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2337\/dc14-1720","article-title":"Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American heart association and american diabetes association","volume":"37","author":"de Ferranti","year":"2014","journal-title":"Diabetes Care."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib10","first-page":"574","article-title":"Lower levels of total HDL and HDL3 cholesterol are associated with albuminuria in normoalbuminuric Type 1 diabetic patients","volume":"36","author":"Bulum","year":"2013","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11306-011-0343-y","article-title":"Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study)","volume":"8","author":"M\u00e4kinen","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib12","first-page":"255","article-title":"Effect of insulin resistance in chronic kidney disease","volume":"5","author":"Frankel","year":"2016","journal-title":"Endocrinol. Metab. Syndr."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib13","first-page":"3","article-title":"Plasma myeloperoxidase measurement in children and adolescents with Type 1 diabetes","volume":"48","author":"Abreg\u00fa","year":"2011","journal-title":"Rev. Argent. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib14","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3923\/ajava.2011.844.850","article-title":"Insulin treatment-induced daily changes to plasma adiponectin and TNF-\u03b1 level and lipid metabolism parameters in dogs suffering from type 1 diabetes mellitus","volume":"6","author":"Mori","year":"2011","journal-title":"Asian J. Animal Veterinary Adv."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.20452\/pamw.1113","article-title":"Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes","volume":"121","author":"Wegner","year":"2011","journal-title":"Pol. Arch. Med. Wewnetrznej"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib16","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.diabet.2009.04.004","article-title":"Lipid disorders in type 1 diabetes","volume":"35","author":"V","year":"2009","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib17","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.2337\/diabetes.51.11.3300","article-title":"Relationship of phospholipid transfer protein activity to HDL and apolipoprotein B-containing lipoproteins in subjects with and without type 1 diabetes","volume":"51","author":"Colhoun","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0026-0495(94)90102-3","article-title":"Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation","volume":"43","author":"Hughes","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib19","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1007\/BF03347057","article-title":"Alterations in arterial pressure in patients with Type 1 diabetes are associated with long-term poor metabolic control and a more atherogenic lipid profile","volume":"34","author":"V\u00edlchez-L\u00f3pez","year":"2011","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib20","first-page":"243","article-title":"Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes","volume":"65","author":"Bulum","year":"2011","journal-title":"Acta Medica Croat."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jcp.53.12.917","article-title":"Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition","volume":"53","author":"Merzouk","year":"2000","journal-title":"J.\u00a0Clin. Pathology"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jacl.2014.03.001","article-title":"Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?","volume":"8","author":"Fekih","year":"2014","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib23","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2337\/diacare.26.5.1356","article-title":"Dietary fats do not contribute to hyperlipidemia in children and adolescents with type 1 diabetes","volume":"26","author":"Wiltshire","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1399-5448.2012.00924.x","article-title":"Glycemic control and high-density lipoprotein characteristics in adolescents with type 1 diabetes","volume":"14","author":"Medina-Bravo","year":"2013","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/diab.30.2.S82","article-title":"High density lipoproteins in diabetes","volume":"30","author":"EA","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib26","first-page":"1067","article-title":"Decreased activity of plasma cholesteryl ester transfer protein in children and adolescents with insulin-dependent diabetes mellitus, Acta Paediatrica","volume":"88","author":"Hayashibe","year":"1999","journal-title":"Int. J. Paediatr."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib27","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1042\/cs1010659","article-title":"High-density lipoprotein composition and paraoxonase activity in type 1 diabetes","volume":"101","author":"Valabhji","year":"2001","journal-title":"Clin. Sci."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib28","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.atherosclerosis.2015.06.040","article-title":"Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration","volume":"241","author":"Denimal","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5551\/jat.32854","article-title":"Role of LCAT in atherosclerosis","volume":"23","author":"Ossoli","year":"2016","journal-title":"J.\u00a0Atheroscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cmet.2016.10.001","article-title":"Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion","volume":"24","author":"Jakulj","year":"2016","journal-title":"Cell metab."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/01.ATV.8.6.737","article-title":"High density lipoprotein cholesterol and mortality. The Framingham heart study","volume":"8","author":"Wilson","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(10)60713-1","article-title":"JUPITER Trial Study Group., HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial","volume":"376","author":"Ridker","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.beem.2013.11.002","article-title":"Should low high-density lipoprotein cholesterol (HDL-C) be treated?","volume":"28","author":"Toth","year":"2014","journal-title":"Best practice & research. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12944-015-0169-0","article-title":"Lipids, blood pressure and kidney update 2015","volume":"14","author":"Banach","year":"2015","journal-title":"Lipids health Dis."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib36","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.2937","article-title":"The not-so-simple HDL story: is it time to revise the HDL cholesterol hypothesis?","volume":"18","author":"Rader","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Group","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib38","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib39","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib41","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib42","first-page":"507","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study, the lancet","volume":"3","author":"Saleheen","year":"2015","journal-title":"Diabetes & Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib43","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.diabet.2009.04.004","article-title":"Lipid disorders in type 1 diabetes","volume":"35","author":"Verges","year":"2009","journal-title":"Diabetes & Metabol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11892-013-0380-1","article-title":"Is the risk and nature of CVD the same in type 1 and type 2 diabetes?","volume":"13","author":"Duca","year":"2013","journal-title":"Curr. diabetes Rep."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib45","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.2174\/0929867321666140414103455","article-title":"Subfractions and subpopulations of HDL: an update","volume":"21","author":"Rizzo","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2362.1991.tb01805.x","article-title":"Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus","volume":"21","author":"Bagdade","year":"1991","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib47","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(77)92274-7","article-title":"The Troms\u00f8 heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study","volume":"1","author":"Miller","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib48","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.273.5277.966","article-title":"Protection against atherogenesis in mice mediated by human apolipoprotein A-IV","volume":"273","author":"Duverger","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib49","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/CIRCULATIONAHA.108.770669","article-title":"Combined statin and niacin therapy remodels the high-density lipoprotein proteome","volume":"118","author":"Green","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib50","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1194\/jlr.M200432-JLR200","article-title":"Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response","volume":"44","author":"Cabana","year":"2003","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-2275(20)38390-5","article-title":"Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins","volume":"30","author":"Cabana","year":"1989","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib52","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib53","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/CS20040312","article-title":"Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease","volume":"108","author":"Kalogerakis","year":"2005","journal-title":"Clin. Sci."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib54","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1194\/jlr.M018671","article-title":"Type I diabetes mellitus decreases in\u00a0vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice","volume":"53","author":"De Boer","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib55","first-page":"11","article-title":"Patients with type 1 diabetes show signs of vascular dysfunction in response to multiple high-fat meals","author":"Lassenius","year":"2014","journal-title":"Nutr. Metabolism"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib56","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacl.2015.10.006","article-title":"Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: partial correction by low-density lipoprotein apheresis","volume":"10","author":"Hussein","year":"2016","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib57","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.111.227181","article-title":"Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia, Arteriosclerosis","volume":"31","author":"Bellanger","year":"2011","journal-title":"Thromb., Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12933-017-0570-2","article-title":"Reduced HDL function in children and young adults with type 1 diabetes","volume":"16","author":"Heier","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib59","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s001250051566","article-title":"Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in Type I diabetes mellitus","volume":"43","author":"Araki","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib60","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1464-5491.2005.01521.x","article-title":"Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus","volume":"22","author":"Oomen","year":"2005","journal-title":"Diabet. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib61","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0306-9877(02)00216-5","article-title":"Does increased leukotriene B4 in type 1 diabetes result from elevated cholesteryl ester transfer protein activity?","volume":"59","author":"Chang","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s005920170027","article-title":"Cholesteryl ester transfer and cholesterol esterification in type 1 diabetes: relationships with plasma glucose","volume":"38","author":"Chang","year":"2001","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib63","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2337\/dc13-1467","article-title":"Glycation of apolipoprotein C1 impairs its CETP inhibitory property: pathophysiological relevance in patients with type 1 and type 2 diabetes","volume":"37","author":"Bouillet","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib64","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0953-6205(00)00101-1","article-title":"High-density lipoprotein cholesterol esterification and transfer rates to lighter density lipoproteins mediated by cholesteryl ester transfer protein in the fasting and postprandial periods are not altered in type 1 diabetes mellitus","volume":"11","author":"Medina","year":"2000","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib65","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Group","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib66","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1053\/meta.2001.23291","article-title":"Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus","volume":"50","author":"Kordonouri","year":"2001","journal-title":"Metabolism Clin. Exp."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(91)90215-O","article-title":"Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus","volume":"86","author":"Mackness","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.18388\/abp.2015_1209","article-title":"Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus","volume":"63","author":"Craciun","year":"2016","journal-title":"Acta biochim. Pol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib69","first-page":"35","article-title":"Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes","volume":"68","author":"Fekih","year":"2017","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib70","first-page":"523","article-title":"Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus","volume":"42","author":"Savu","year":"2014","journal-title":"J.\u00a0Int. Med. Res."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib71","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1464-5491.2002.00660.x","article-title":"Paraoxonase gene cluster is a genetic marker for early microvascular complications in Type 1 diabetes","volume":"19","author":"Kao","year":"2002","journal-title":"Diabet. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib72","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacl.2016.01.001","article-title":"Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in type 1 diabetes","volume":"10","author":"Jarvie","year":"2016","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1479164109346358","article-title":"Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria","volume":"7","author":"Miller","year":"2010","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib74","series-title":"Assessment of OxLDL, Anti-oxLDL Antibodies and Lipoprotein-associated Phospholipase A2 as Cardiovascular Risk Markers in Obese Adolescents with and without T1DM, Bulletin of Faculty of Pharmacy","author":"Omar","year":"2017"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dia.2010.0175","article-title":"Lipoprotein-associated phospholipase A2 activity predicts progression of subclinical coronary atherosclerosis","volume":"13","author":"Kinney","year":"2011","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib76","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/ndt\/15.7.994","article-title":"Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria","volume":"15","author":"Cavallo-Perin","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib77","first-page":"1181","article-title":"Lipoprotein-associated phospholipase A2 activity and low-density lipoprotein subfractions after a 2-year treatment with atorvastatin in adolescents with type 1 diabetes","volume":"29","author":"Krebs","year":"2016","journal-title":"J.\u00a0Pediatr. Endocrinol. Metabol. JPEM"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib78","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejim.2014.10.010","article-title":"An inverse-to-anticipated relationship of Lp-PLA2 activity in diabetes: reflection of underlying autoimmune activation","volume":"26","author":"Onat","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib79","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O'Donoghue","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jama.2013.282836","article-title":"Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib81","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2013.06.044","article-title":"Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study","volume":"62","author":"Holmes","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib82","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.diabres.2009.01.014","article-title":"Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes","volume":"84","author":"Heilman","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib83","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1753-0407.12129","article-title":"C-Reactive protein and soluble intracellular adhesion molecule-1 are related to pulse wave reflection in type 1 diabetes","volume":"6","author":"Rogowicz-Frontczak","year":"2014","journal-title":"J.\u00a0Diabetes"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib84","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/ATVBAHA.117.309275","article-title":"A\u00a0shift in ApoM\/S1P between HDL-particles in women with type 1 diabetes mellitus is associated with impaired anti-inflammatory effects of the ApoM\/S1P ComplexHighlights","volume":"37","author":"Frej","year":"2017","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib85","first-page":"2015","article-title":"A\u00a0cross-sectional study demonstrating increased serum amyloid a related inflammation in high-density lipoproteins from subjects with type 1 diabetes mellitus and how this association was augmented by poor glycaemic control","author":"McEneny","year":"2015","journal-title":"J.\u00a0Diabetes Res."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.diabres.2012.10.022","article-title":"Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes","volume":"99","author":"Murakami","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib87","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jdiacomp.2012.06.016","article-title":"Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients","volume":"27","author":"Overgaard","year":"2012","journal-title":"J.\u00a0diabetes its Complicat."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib88","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2006-924265","article-title":"Improved glycaemia in type 1 diabetes results in decreased levels of soluble adhesion molecules with no change in serum adiponectin or most acute phase proteins","volume":"114","author":"Heliovaara","year":"2006","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00592-015-0770-8","article-title":"Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial","volume":"53","author":"Costacou","year":"2016","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cyto.2017.03.001","article-title":"High-density lipoprotein immunomodulates the functional activities of macrophage and cytokines produced during ex\u00a0vivo macrophage-CD4+ T cell crosstalk at the recent-onset human type 1 diabetes","volume":"96","author":"Benghalem","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/2040622315598502","article-title":"Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population","volume":"6","author":"Lee","year":"2015","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib92","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Group","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib93","first-page":"308","article-title":"HDL\u2013is it too big to fail?, Nature reviews","volume":"9","author":"Ng","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib94","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2362.2011.02636.x","article-title":"CETP-mediated cholesteryl ester enrichment of apoB subclasses in type 1 diabetes","volume":"42","author":"Bagdade","year":"2012","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib95","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0026-0495(98)90045-2","article-title":"Effects of a short-acting insulin analog (insulin lispro) versus regular insulin on lipid metabolism in insulin-dependent diabetes mellitus","volume":"47","author":"Caix\u00e0s","year":"1998","journal-title":"Metabolism Clin. Exp."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib96","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1590\/S0004-27302009000100014","article-title":"Lipid transfer to HDl in women with type 1 diabetes","volume":"53","author":"Feitosa","year":"2009","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib97","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/j.lpm.2014.10.020","article-title":"Is paraoxonase 1 a marker of cardiovascular risk in youth with type 1 diabetes? (Study about 109 cases)","volume":"44","author":"Fekih","year":"2015","journal-title":"Presse Medicale"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib98","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0168-8227(92)90143-F","article-title":"A\u00a0cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with Type 1 (insulin-dependent) diabetes mellitus","volume":"18","author":"Winocour","year":"1992","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib99","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2337\/dc13-1467","article-title":"Glycation of apolipoprotein C1 impairs its CETP inhibitory property: pathophysiological relevance in patients with type 1 and type 2 diabetes","volume":"37","author":"Bouillet","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2017.10.018_bib100","first-page":"17","article-title":"Concentrations of lipoproteins and apolipoproteins in young subjects with insulin-dependent diabetes. Relationship with glycosylated haemoglobin and fructosamine","volume":"19","author":"Willems","year":"1990","journal-title":"Presse Medicale"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:41:23Z","timestamp":1750959683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":100,"alternative-id":["S0021915017313382"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDL functionality in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}